Liver International

1/2
⬆️ liver tests may not always indicate a higher risk of serious liver disease

Genetic variants influencing common liver test results (like GGT & bilirubin) don't always correlate with higher cirrhosis risk 🤔

🔓bit.ly/3VgbxO4

#livertwitter

1/2
A multicenter 🇪🇸 study shows that #Rituximab is a safe & effective option for patients with refractory autoimmune hepatitis

It achieved complete biochemical response in 89% of cases, ⬇️ need for immunosuppressants & corticosteroids

🔓 bit.ly/4ehFh4u

#Livertwitter

1/2
Cholangiocarcinoma is a rare but serious liver cancer😕

🇫🇷 French experts have created guidelines to help doctors diagnose and treat it

🔬 Covers risk factors, screening, diagnosis, and treatment options

🔓 bit.ly/3S6mCzQ

#livertwitter

1/2
📢 New research reveals the changing landscape of alcohol-associated liver disease (ALD)

📈 Cases are on the rise in young people, women, and ethnic minorities

🔓 bit.ly/3XQDjTp

@juanpabloarab @geneyim @singal_ashwani

#livertwitter

1/2
📊 Study of liver biopsies in systemic mastocytosis:

🔬 High mast cell infiltration linked to ↑ alkaline phosphatase
🧬 CD30+ mast cells more common with high infiltration
❇️ Fibrosis severity associated with portal hypertension

🔓 bit.ly/3W20jOb

#livertwitter